Christine M. Palermo, Ph.D., DABT, is Director of Regulatory Sciences at The Acta Group (Acta®). Dr. Palermo provides Acta clients with global strategy in chemical regulatory compliance, risk assessment, and product stewardship, assisting clients to commercialize new products and expand markets for existing product portfolios. Dr. Palermo deploys the extensive U.S. domestic and international experience she gained as a regulatory sciences principal and leader of global toxicology for ExxonMobil (EM) Biomedical Sciences to advise Acta clients regarding ongoing and anticipated regulatory risk management in the United States, European Union (EU), and Asia for new and existing chemicals and chemical products, including those subject to heavy regulatory scrutiny.
Dr. Palermo is a recognized leader in the advancement of science-based regulatory decision-making. Through her involvement with the European Chemical Industry Council (CEFIC), the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), the World Health Organization/International Programme on Chemical Safety Mode of Action/Human Relevance Framework (WHO/IPCS MOA HRF), and other industry organizations, Dr. Palermo has worked to evolve the internationally recognized evidence integration framework for assessing human relevance of chemical mediated outcomes in animals, and to advance technical approaches for endocrine disruptor identification, reproductive hazard identification, and a risk-based polymer safety decision framework to inform chemical management approaches. She has a long and distinguished bibliography of peer-reviewed scientific papers and articles published in Reproductive Toxicology, Toxicology Letters, and Regulatory Toxicology and Pharmacology, among other prominent scientific journals.
More Legal and Business Bylines From Christine M. Palermo, Ph.D., DABT
